Back to Awarded Treatment Trials
Awarded Trial: 02T-156
Grant ID
02T-156
Illness
Schizophrenia
Primary Drug/Intervention
Panax ginseng
Primary Dosage
100 mg
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Completed
Investigator
Chiu
Sample Size
60
Duration of Study Period for Each Subject
8 weeks
Outcome Measurements
SANS, HAMD-D, BPRS, PANSS, Cognitive battery
Results
Forty-two patients completed the trial. The crossover design was unable to rule out carryover effects in those subjects that received ginseng first. Excluding data from the crossover design, patients receiving ginseng showed a significant reduction in SANS, HAM-D, total PANSS, and PANSS negative subscale score. There was no effect on cognitive measures.
Publication
N/A
Link
N/A
PI Name
Simon Chiu
Degree
MD
Center
MSA LTD.
Institution
University of Western Ontario Research Park
Address
100 Collip Circle, Suite 230 A
City or Town
London
State or Province
Ontario
Zip or Postal Code
N6G 4X8
Country
Canada
Email Address
schiu3207@rogers.com